NANDRO INJECTION

NANDRO INJECTION	Nandrolone decanoate 25 mg,50 mg, 100 mg Injections
Composition :	Each ampoule contains 1 ml of 25 mg/50 mg/100mg/ml Nandrolone decanoate
Indications :	For use in osteoporosis in post-menopausal women
Contraindications :	Hypersensitivity to the active substance or to any of the excipients, including arachis oil. Nandro injection is therefore contraindicated in patients allergic to peanuts or soya. Pregnancy Breast-feeding Porphyria
Adverse Effects :	Virilism, lipids abnormal, libido increased, hypertension, dysphonia, nausea, hepatic function abnormal, peliosis hepatis, liver tumours, acne, pruritus, hirsutism, decreased urine flow, oedema, Injection site reaction Sodium retention.
Dosage :	Post-menopausal women 50mg every three weeks The duration of treatment depends on the clinical response and the possible occurrence of side-effects. We would recommend that the effectiveness of therapy be monitored with the appropriate methods for osteoporosis on a 6-12 monthly basis.